(Q28271599)

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Enteric parasites and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Intestinal strongyloidiasis: recognition, management, and determinants of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Risk factors for strongyloidiasis. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Severe strongyloidiasis in corticosteroid-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Opportunistic Strongyloides stercoralis infection in lymphoma patients. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Biology and immunology of human strongyloidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Imported strongyloidosis: a longitudinal analysis of 31 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Strongyloidiasis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Colitis in an alcohol-dependent woman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

AIDS and strongyloidiasis in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Diagnosis of Strongyloides stercoralis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Reduction in interleukin-2-producing cells but not Th1 to Th2 shift in moderate and advanced stages of human immunodeficiency virus type-1-infection: direct analysis of intracellular cytokine concentrations in CD4+ CD8- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Human T-lymphotropic virus 1: recent knowledge about an ancient infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

The immune response to nematode parasites: modulation of mast cell numbers and function during Strongyloides stercoralis infections in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020

Opportunistic strongyloidiasis in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.020